Showing results (351-360 of 527) with videos related to

Sort By:
Pageof 53
Anticancer Research|December 1, 2021
Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal CancerYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast CancerKayo Fukui, Norio Masumoto, Erika Yokoyama, et al.
International Journal of Clinical Oncology|January 16, 2023
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning systemShota Miyoshi, Ikuno Nishibuchi, Yuji Murakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2009
[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]Hirokazu Watanabe, Morihito Okada, Yasushi Kaji, et al.
Annals of Surgical Oncology|January 25, 2019
Clinical Significance of <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell CarcinomaYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Oncology Letters|February 23, 2018
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasiaKei Kushitani, Vishwa Jeet Amatya, Amany Sayed Mawas, et al.
Molecular and Clinical Oncology|February 14, 2018
Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patientsKazuo Matsuura, Toshiyuki Itamoto, Midori Noma, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2015
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinomaShuji Murakami, Hiroyuki Ito, Norifumi Tsubokawa, et al.
Diabetology International|October 20, 2025
Dynamic changes of blood glucose level during capivasertib treatment in metastatic breast cancer: a case reportShinsuke Sasada, Haruya Ohno, Hisae Taonouchi, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2021
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancerAi Amioka, Takayuki Kadoya, Satoshi Sueoka, et al.
Pageof 53